NCT06674070View on ClinicalTrials.gov

SCN2A Polymorphisms Are Associated With Response to Valproic Acid in Paediatric Population(Pakistan)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2024

Conditions
Epilepsy
Interventions
GENETIC

Valproic Acid

syrup/ tablet EPIVAL (250mg

Trial Locations (1)

Unknown

IIMC, Riphah International University, Islamabad

All Listed Sponsors
lead

Riphah International University

OTHER

NCT06674070 - SCN2A Polymorphisms Are Associated With Response to Valproic Acid in Paediatric Population(Pakistan) | Biotech Hunter | Biotech Hunter